RA stands for rheumatoid arthritis, a chronic condition where the immune system mistakenly attacks the lining of the joints. It affects roughly 0.25% to 1% of people worldwide and is two to four times more common in women than men. Unlike the wear-and-tear arthritis most people associate with aging, RA is driven by inflammation and can affect the whole body, not just the joints.
How RA Differs From Regular Arthritis
Most people who hear “arthritis” think of osteoarthritis, the kind that comes from decades of use and typically shows up later in life. In osteoarthritis, the cartilage cushioning a joint gradually wears down until bone grinds against bone. The pain tends to build slowly over months or years and usually gets worse with activity.
RA works differently. It’s an autoimmune disease, meaning your immune system, which normally fights infections, turns on your own tissues instead. In RA, the primary target is the synovium, a thin membrane that lines and lubricates your joints. The immune system floods the synovium with inflammatory cells, causing it to thicken and swell. Over time, this overgrown tissue (called pannus) invades the surrounding cartilage and bone, gradually destroying the joint from the inside.
The joints RA favors are different, too. It most commonly hits the hands, wrists, and feet, and it tends to appear on both sides of the body at the same time. If your right wrist is affected, your left wrist probably is too. Osteoarthritis often targets the joint closest to the fingertip, while RA usually spares that joint entirely. RA also progresses faster. Symptoms typically worsen over several weeks or a few months rather than years.
What Happens Inside the Body
The chain reaction behind RA involves several types of immune cells working together in a destructive feedback loop. White blood cells called T cells become activated and release signaling molecules (cytokines) that recruit more immune cells to the joint lining. B cells join in, producing antibodies and further amplifying the immune response. Macrophages, another type of immune cell, act as the main drivers of tissue damage, pumping out inflammatory signals that stimulate still more cells, including bone-destroying cells called osteoclasts.
What makes RA especially persistent is that this process becomes self-sustaining. Even if the original trigger disappears, the inflammatory signals keep feeding forward, each wave of immune activity stimulating the next. New blood vessels grow into the inflamed tissue, supplying it with oxygen and nutrients that keep the cycle going. This is why RA rarely resolves on its own and why early treatment matters so much.
Common Symptoms
The hallmark of RA is joint pain and swelling that’s worst in the morning. Morning stiffness lasting 30 minutes or longer is a classic sign, and many people find their joints also stiffen after sitting for long periods. The affected joints feel warm and puffy, not just sore. Because the disease is driven by inflammation rather than mechanical wear, the pain doesn’t necessarily improve with rest the way osteoarthritis pain sometimes does.
Fatigue is another major symptom that often surprises people. The systemic inflammation can leave you feeling drained in a way that sleep doesn’t fix. Low-grade fevers, loss of appetite, and a general sense of feeling unwell are also common, especially during flares.
Effects Beyond the Joints
RA is not just a joint disease. The chronic inflammation circulating through the body can damage organs far from the joints. Cardiovascular disease is the most common cause of death in people with RA. Compared to the general population, people with RA have roughly double the risk of heart attack and up to 50% higher cardiovascular death rates.
Lung problems are the second leading cause of death in RA and affect 30% to 40% of patients. RA can cause scarring in the lung tissue, inflammation of the airways, or fluid around the lungs. In 20% to 30% of those cases, the lung complications actually appear before any joint symptoms do. The nervous system can also be affected, with growing evidence linking the chronic inflammation of RA to higher rates of dementia. Firm lumps under the skin, called rheumatoid nodules, and inflammation of blood vessels (vasculitis) are other possible complications.
How RA Is Diagnosed
There’s no single test that confirms RA. Doctors use a combination of physical examination, blood tests, and a scoring system to reach a diagnosis. The formal classification requires at least one joint with visible swelling that can’t be better explained by another condition, plus a score of 6 or higher out of 10 across four categories: how many and which joints are involved, blood test results, markers of inflammation, and how long symptoms have lasted.
Two blood tests play a central role. Rheumatoid factor (RF) is the older of the two, with a sensitivity between 55% and 90%, meaning it catches most but not all cases. The anti-CCP test is more precise: when it’s positive, there’s roughly a 90% to 98% chance the person truly has RA, though it only picks up about 65% of cases. Some people with RA test negative on both, a situation called seronegative RA. Doctors also check markers of inflammation in the blood, such as CRP and ESR, which tend to be elevated during active disease.
The scoring system awards more points when many small joints are involved (especially in the hands and feet), when blood tests are strongly positive, and when symptoms have lasted six weeks or longer. A high score combined with clinical judgment allows for an earlier diagnosis than older methods, which required waiting for visible joint damage on X-rays.
Treatment Approach
The goal of modern RA treatment is to stop the inflammatory process before it causes permanent joint damage. The standard first step is a medication called methotrexate, often paired with a short course of corticosteroids to bring inflammation under control quickly. Most guidelines recommend reassessing within three to six months. If methotrexate alone isn’t enough, the next step depends on how aggressive the disease looks.
For people with risk factors for worse outcomes, like strongly positive blood tests, high disease activity, or early signs of bone erosion, doctors typically add a biologic medication. Biologics are drugs designed to block specific parts of the immune cascade. Some target the inflammatory signaling molecule TNF, which is one of the key drivers of joint destruction. Others work by blocking different immune signals or depleting certain immune cells. A newer class of oral medications works by interrupting the internal signaling pathways that immune cells use to activate.
Treatment has transformed dramatically over the past two decades. With early, aggressive therapy, many people with RA achieve low disease activity or even remission, where symptoms are minimal and joint damage slows or stops. The key is starting treatment early. Joint erosion can begin within the first year, and damage that’s already happened can’t be reversed. People with RA typically stay on some form of medication long-term, with their treatment plan adjusted over time based on how well their disease is controlled.